Integrated Multivariate Analysis with Nondetects for the Development of Human Sewage Source-Tracking Tools Using Bacteriophages of Enterococcus faecalis. Wangkahad B, Mongkolsuk S, Sirikanchana K. Environ Sci Technol. 2017 Jan 10. doi: 10.1021/acs.est.6b04714. [Epub ahead of print]

28 Dec 2017
0
0

Integrated Multivariate Analysis with Nondetects for the Development of Human Sewage Source-Tracking Tools Using Bacteriophages of Enterococcus faecalis.
Wangkahad B, Mongkolsuk S, Sirikanchana K.
Environ Sci Technol. 2017 Jan 10. doi: 10.1021/acs.est.6b04714. [Epub ahead of print]

Tags

Share this

Related Posts

The iron-sulphur cluster biosynthesis regulator IscR contributes to iron homeostasis and resistance to oxidants in Pseudomonas aeruginosa Romsang A, Duang-Nkern J, Leesukon P, Saninjuk K, Vattanaviboon P, Mongkolsuk S. PLoS One. 2014 Jan 22;9(1):e86763. doi: 10.1371/journal.pone.0086763. eCollection 2014.
28 Dec 2014
0

The iron-sulphur cluster biosynthesis regulator IscR contributes to iron homeostasis and resistance to oxidants in Pseudomonas aeruginosa Romsang A, Duang-Nkern J, Leesukon P, Saninjuk K, Vattanaviboon P, Mongkolsuk S. PLoS One. 2014 Jan 22;9(1):e86763. doi: 10.1371/journal.pone.0086763. eCollection 2014.

The iron-sulphur cluster biosynthesis regulator IscR contributes to iron homeostasis and resistance to oxidants in Pseudomonas aeruginosa Romsang A, Duang-Nkern J, Leesukon P, Saninjuk K, Vattanaviboon P, Mongkolsuk S. PLoS One. 2014 Jan 22;9(1):e86763. doi: 10.1371/journal.pone.0086763. eCollection 2014.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More